- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 18.12.25 | As year-end nears, pharma groups plump up their pipelines | ||
| 18.12.25 | Lilly points to long-lasting weight loss with orforglipron | ||
| 18.12.25 | Datroway filed for TNBC in EU after data delay | ||
| 18.12.25 | Takeda plans filings for Sotyktu rival on new psoriasis data | ||
| 18.12.25 | MSD claims two national priority vouchers; report | ||
| 18.12.25 | As year-end nears, pharma groups boost their pipelines | ||
| 17.12.25 | Padcev/Keytruda scores again in early bladder cancer | ||
| 17.12.25 | DBV gets peanut allergy therapy programme back on track | ||
| 17.12.25 | LIB takes aim at cholesterol market with new PCSK9 option | ||
| 17.12.25 | UK, US approve GSK's twice-yearly asthma drug | ||
| 17.12.25 | CDC signs off on advice ending universal hepatitis B jabs | ||
| 16.12.25 | Allergy Tx plots grass pollen jab launch after German okay | ||
| 16.12.25 | Chai raises $130m for AI drug discovery platform | ||
| 16.12.25 | Prof Jonathan Benger named as NICE's new CEO | ||
| 16.12.25 | Enhertu moves into frontline breast cancer treatment | ||
| 16.12.25 | J&J claims FDA's latest national priority voucher | ||
| 15.12.25 | Kyverna rises on stiff person syndrome data | ||
| 15.12.25 | J&J's run of talc lawsuit setbacks continues | ||
| 15.12.25 | Sanofi gets double blow for MS drug tolebrutinib | ||
| 15.12.25 | GSK closes on approval of asthma hope depemokimab | ||
| 15.12.25 | Sobi pays $1.5bn for Arthrosi to grow in gout | ||
| 12.12.25 | CHMP decision levels the playing field for GSK's RSV jab | ||
| 12.12.25 | UK teams up with Singapore on healthtech regulation | ||
| 12.12.25 | SanegeneBio raises $110m for RNAi, plus other financings | ||
| 11.12.25 | FDA clears first at-home device for depression |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .